bOPV registration Countries using and planning to introduce IPV December 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 486258
Download Presentation The PPT/PDF document "Countries using and planning to introduc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Countries using and planning to introduce IPV and the global status of
bOPV
registrationSlide2
Countries using and planning to introduce IPVDecember 2015 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (
bOPV
), in preparation for the switch from trivalent OPV (
tOPV
) to
bOPV
.
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact
polio2@who.int
with any questions or updates on this data.
Definitions
Formal decision
to introduce:
The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for
Gavi
eligible countries, a complete application for IPV has been submitted to the
Gavi
Secretariat.
Intent
to introduce:
The country has informally indicated that it plans to introduce IPV, e.g. planning an application to
Gavi
,
or by requesting technical assistance to develop an IPV introduction plan.
Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the
Polio Eradication and Endgame Strategic Plan
.Slide3
Countries using IPV vaccine to date
and formal decision/intent to introduce
Data source: WHO/IVB Database, as of 03 December 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 December 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(132 countries or 68%)
Formal commitment to introduce in 2015
(24 countries or 12%)
(38 countries or 20%)
Introduction delayed to 2016 due to global IPV vaccine shortage
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015);
Bahamas, Lao
People's Dem Rep, Nauru, Samoa (October 2015);
Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu
& Yemen
(November 2015
); Cambodia & Kenya (December 2015) Slide4
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
Data source: WHO/IVB Database, as of 03 December 2015Map production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 3 December 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(132 countries or 68%)
Gavi
countries with formal commitment to introduce in 2015-16
(38 countries or 20%)
Non
Gavi
countries with formal commitment to introduce in 2015-16
(24 countries or 12%)
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015);
Bahamas, Lao
People's Dem Rep, Nauru, Samoa (October 2015);
Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu
& Yemen
(November 2015
); Cambodia & Kenya (December 2015) Slide5
62 countries introducing IPV between 3 December 2015 and September 2016
Tier 1 countries are countries with
cVDPV2 transmission or
cVDPV2
reported since 2000 & WPV endemic
countries
Tier
2 countries are countries
with cVDPV 1/3 since 2000 or large /medium
size countries with DTP3 coverage <80% in the past 3 years as per WUENIC
Dec-15
Jan-16
Feb-16
Apr-16
After April-16
Algeria
Argentina
Azerbaijan
Cabo Verde
Angola
Barbados
Bolivia
Djibouti
Armenia
Belize
El Salvador
Egypt
Burkina Faso
Chile
Haiti
Equatorial Guinea
Eritrea
Congo
Mali
Guinea-Bissau
Ghana
Cuba
Saint Kitts and Nevis
Lesotho
Indonesia
Dominican Republic
Uganda
Sao Tome & Principe
Kyrgyzstan
EcuadorVenezuela SwazilandLiberiaEthiopia MalawiFiji MongoliaGabon Rep. of MoldovaGeorgia RwandaGuatemala Sierra LeoneHonduras TajikistanIraq TogoMauritius TurkmenistanMyanmar United Rep. of TanzaniaParaguay UzbekistanSomalia Viet NamSouth Sudan ZambiaThailand ZimbabweTimor-Leste Tonga Trinidad and Tobago 2481821
Data source: WHO/IVB Database, as of 03 December 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health OrganizationSlide6
Tier 1 and 2 Countries using IPV vaccine to dateand formal decision to introduce
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countriesTier 2 countries are countries with
cVDPV
1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
Country Tier classification was updated on 15 October 2015
Data source: WHO/IVB Database, as of 03 December 2015,
based on 36 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health OrganizationDate of slide: 3 December 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduction to date
(9 countries or 25%)
Formal commitment to introduce in 2015
(21 countries or 58%)
Not applicable / Not available / Not Tier 1 or 2 countries
(158 countries)
Formal commitment to introduce in 2016
(6 countries or 17%)
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015);
Guinea, India, Mauritania, Mozambique
& Yemen
(
November 2015
); Cambodia & Kenya (December 2015)Slide7
Middle Income Countries using IPV vaccine to date
and formal decision to introduceData source: WHO/IVB Database, as of 03 December 2015 based on 100middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 December 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(62 countries or 62%)
Formal commitment to introduce in 2015
(18 countries or 18%)
Formal commitment to introduce in 2016
(20 countries or 20%)
Not available / Not applicable / Non MIC countries
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015);
M
aldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015);
Bhutan
, Cameroon,
Pakistan & Sri Lanka (July 2015
); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana,
India, Mauritania, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu , Vanuatu &
Yemen (November 2015
); Kenya (December 2015)
Slide8
IPV introduction status and planned introductionby quarter by the end of 2015
Data source: WHO/IVB Database, as of 03 December 2015Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 December 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(132 countries or 68%)
(38 countries or 20%)
Introduction delayed to 2016 due to global IPV vaccine shortage
Not available
(24 countries or 12%)
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015);
Bahamas, Lao
People's Dem Rep, Nauru, Samoa (October 2015);
Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu
& Yemen
(November 2015
); Cambodia & Kenya (December 2015)
Introduction planned in
December 2015 Slide9
Overview of Global birth cohort by
IPV status/tier(100% = 136.1 million births in 2015)
Data source: WHO/IVB Database, as of
03 December
2015 and
United Nations, Department of
Economic and
Social Affairs, Population Division (2015). World Population Prospects: The 2015
RevisionSlide10
bOPV registration
status for routine immunization
Approval for use
(
112
countries or
76%)
Review in progress
(19
countries or
13%)
Pending submission
(14 countries or 9%)
Not available/ non switch countries
Not applicable (switch area territories)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
(46 countries) + 3 countries switching from tOPV to IPV
Date of slide: 6 November 2015
Data source: WHO/IVB Database, as of 03 December 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization